
The disposable pen injector independently developed by Wanhai Medical has successfully obtained its Class II medical device registration certificate. This represents official recognition from the national medical products regulatory authority regarding the product's safety, efficacy and quality controllability, marking that the product is now officially qualified for legal market launch and can fully serve patients in precision drug delivery scenarios.
Building Dreams Together
Targeting core market demands, this disposable pen injector features precise dosing, user-friendly operation and reliable safety. It is compatible with a wide range of medications, including insulin, GLP‑1, growth hormone and other therapeutic drugs. This certification milestone represents a major achievement for Wanhai Medical in medical device research and development as well as regulatory compliance, demonstrating the company's technological strength and compliance capabilities in the field of drug delivery devices.
In the future, Wanhai Medical will continue to focus on the drug delivery device sector, taking compliance as the foundation and innovation as the driving force. We will launch more high‑quality pen injectors, striving to improve patient experience and advance biopharmaceutical innovation.